Inari Medical, Inc. (NARI)
NASDAQ: NARI · IEX Real-Time Price · USD
37.11
-0.82 (-2.16%)
At close: Apr 23, 2024, 4:00 PM
37.45
+0.34 (0.92%)
After-hours: Apr 23, 2024, 6:10 PM EDT
Inari Medical Market Cap
Inari Medical has a market cap or net worth of $2.15 billion as of April 23, 2024. Its market cap has decreased by -38.30% in one year.
Market Cap
2.15B
Enterprise Value
2.07B
1-Year Change
-38.30%
Ranking
Category
Stock Price
$37.11
Market Cap Chart
Since May 22, 2020, Inari Medical's market cap has increased from $1.96B to $2.15B, an increase of 9.80%. That is a compound annual growth rate of 2.41%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 22, 2024 | 2.20B | -1.71% |
Apr 19, 2024 | 2.24B | -0.13% |
Apr 18, 2024 | 2.24B | -0.16% |
Apr 17, 2024 | 2.24B | -1.02% |
Apr 16, 2024 | 2.27B | -0.99% |
Apr 15, 2024 | 2.29B | -3.16% |
Apr 12, 2024 | 2.36B | -1.78% |
Apr 11, 2024 | 2.41B | -3.60% |
Apr 10, 2024 | 2.50B | -0.23% |
Apr 9, 2024 | 2.50B | 1.01% |
Apr 8, 2024 | 2.48B | 1.42% |
Apr 5, 2024 | 2.44B | -0.47% |
Apr 4, 2024 | 2.45B | -2.06% |
Apr 3, 2024 | 2.51B | -6.39% |
Apr 2, 2024 | 2.68B | -2.12% |
Apr 1, 2024 | 2.73B | -1.66% |
Mar 28, 2024 | 2.78B | 1.22% |
Mar 27, 2024 | 2.75B | 2.80% |
Mar 26, 2024 | 2.67B | 8.78% |
Mar 25, 2024 | 2.46B | -4.36% |
Mar 22, 2024 | 2.57B | -1.99% |
Mar 21, 2024 | 2.62B | -1.16% |
Mar 20, 2024 | 2.65B | 1.11% |
Mar 19, 2024 | 2.62B | 8.69% |
Mar 18, 2024 | 2.41B | 2.41% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
ICU Medical | 2.31B |
Merus | 2.30B |
Rhythm Pharmaceuticals | 2.29B |
STAAR Surgical Company | 2.27B |
Integra LifeSciences Holdings | 2.24B |
CONMED | 2.24B |
agilon health | 2.24B |
Denali Therapeutics | 2.23B |